Suraksha Diagnostic Limited — PPTs, 08-02-2025: Investor Presentation

Suraksha Diagnostic Limited reported strong results for Q3 FY25 with total income reaching ₹601.12 million, representing a 14% year-over-year increase. The EBITDA also showed robust growth at ₹188.55 million, an increase of 16.7%, while the profit after tax climbed to ₹59.85 million, up 31.9% year-over-year. For the nine-month period, total income was ₹1,900.27 million, a 14.4% rise, with EBITDA up 22.4% to ₹650.84 million and PAT growing by 41.7% to ₹238.07 million.

The company continues to strengthen its position as the largest integrated diagnostic chain in Eastern India, with a focus on expanding its network and offering a comprehensive range of diagnostic services. Its operational model, which integrates technology and enhances customer convenience, is designed to drive future growth. The positive performance metrics coupled with a strategic focus on organic and inorganic growth strategies suggest a favorable outlook for investors. Opportunities in the diagnostic market, particularly within the underserved eastern region, present significant growth potential.